Philips may divide orders into batches to be delivered in phases, so that the company can simultaneously serve multiple countries/regions in need. provided by the WHO and Johns Hopkins Coronavirus Resource Center) and the available critical care capacity. Philips believes that critical medical equipment, such as hospital ventilators, should be made available across the world using a fair and ethical approach to allocate supply to acute patient demands based on data such as the COVID-19 statistics per country/region (e.g. As a result of its production ramp up, Philips was able to deliver an additional batch of ventilators to one of New York’s hospitals, to help provide immediate relief to the surge of COVID-19 patients within the city. In the first three months of this year, Philips already delivered several thousand ventilators to U.S. government have agreed to work together to accelerate access to critical materials and components, expedite logistics and regulatory approvals, in order to rapidly increase the production of ventilators. In line with the recent call to action by the International Chamber of Commerce (ICC) and World Health Organization (WHO), Philips and the U.S. in the coming weeks and months through December 2020.” We believe in fair allocation of scarce medical equipment to those who need it the most, and we are ramping up to deliver 43,000 units to the most critical regions in the U.S. government in our efforts to aggressively increase the production of hospital ventilators. “There is an unprecedented global demand for medical equipment to help diagnose and treat patients with COVID-19. and across the globe,” said Frans van Houten, CEO of Royal Philips.

government to help save lives in the U.S. “We are actively collaborating with the U.S. Philips will invest several tens of millions in its ventilator manufacturing sites in the U.S. Throughout Philips, we strive to maximize the impact of innovation, always looking further ahead and considering the future while staying firmly rooted in what matters now. Such ventilators are critical for the treatment of patients with the new coronavirus disease (COVID-19).

Philips plans to double the production by May 2020 and achieve a four-fold increase by the third quarter of 2020 for supply to the U.S. Government and Philips agreed to team up to increase the production of hospital ventilators in its manufacturing sites in the U.S. Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the U.S.

Usa philips com news center